Associated Papers
A Global Approach to the Long-Term Follow-up of 17 Families with Bilateral Macronodular Adrenal Disease.
Charchar HLS et al.
The Journal of Clinical Endocrinology and Metabolism, 2025
Advancements in the research of the structure, function, and disease-related roles of ARMC5.
Qu Y et al.
Frontiers of Medicine, 2025
The mutational landscape of ARMC5 in Primary Bilateral Macronodular Adrenal Hyperplasia: an update.
Bouys L et al.
Orphanet Journal of Rare Diseases, 2025
Neuroradiological features of patients with bilateral macronodular adrenocortical disease and meningiomas associated or not with genetic variants of ARMC5- a case series.
Salame AAM et al.
Journal of Neuro-oncology, 2024
Whole-Exome Sequencing Identifies Pathogenic Germline Variants in Patients with Lynch-Like Syndrome.
Dos Santos W et al.
Cancers, 2022
36077770 (PubMed )
Supplement: cancers-14-04233-s001.zip › cancers-1703647-Supplementary_Table_S3.xlsx › Supp.Table_S3
Genetic alteration of ARMC5 in a patient diagnosed with meningioma and primary macronodular adrenal hyperplasia: a case report.
Jojima T et al.
European Journal of Endocrinology, 2020
A multicenter experience on the prevalence of ARMC5 mutations in patients with primary bilateral macronodular adrenal hyperplasia: from genetic characterization to clinical phenotype.
Albiger NM et al.
Endocrine, 2017
Molecular and clinical evidence for an ARMC5 tumor syndrome: concurrent inactivating germline and somatic mutations are associated with both primary macronodular adrenal hyperplasia and meningioma.
Elbelt U et al.
The Journal of Clinical Endocrinology and Metabolism, 2015
ARMC5 mutations are a frequent cause of primary macronodular adrenal Hyperplasia.
Alencar GA et al.
The Journal of Clinical Endocrinology and Metabolism, 2014
Select a paper to view details